Previous studies indicated that successfully blocking TLR4 signaling significantly reduces the pathogenesis associated with bacterial sepsis and lethal influenza infection indicating the critical role of this innate immune-signaling pathway in exasperating immunological responses [63, 64]. The gene discussed is TLR4; the disease is bacterial infectious disease with sepsis.